- Home
- HUSA vs GOVX Comparison
HUSA vs GOVX Comparison
Compare HUSA & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUSA
- GOVX
- Stock Information
- Founded
- HUSA N/A
- GOVX 2001
- Country
- HUSA United States
- GOVX United States
- Employees
- HUSA N/A
- GOVX N/A
- Industry
- HUSA Oil & Gas Production
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- HUSA Energy
- GOVX Health Care
- Exchange
- HUSA Nasdaq
- GOVX Nasdaq
- Market Cap
- HUSA 14.4M
- GOVX 17.1M
- IPO Year
- HUSA N/A
- GOVX N/A
- Fundamental
- Price
- HUSA $1.57
- GOVX $2.57
- Analyst Decision
- HUSA
- GOVX Strong Buy
- Analyst Count
- HUSA 0
- GOVX 5
- Target Price
- HUSA N/A
- GOVX $14.20
- AVG Volume (30 Days)
- HUSA 558.2K
- GOVX 3.6M
- Earning Date
- HUSA 11-22-2024
- GOVX 11-12-2024
- Dividend Yield
- HUSA N/A
- GOVX N/A
- EPS Growth
- HUSA N/A
- GOVX N/A
- EPS
- HUSA N/A
- GOVX N/A
- Revenue
- HUSA $623,103.00
- GOVX $3,090,161.00
- Revenue This Year
- HUSA N/A
- GOVX N/A
- Revenue Next Year
- HUSA N/A
- GOVX $565.58
- P/E Ratio
- HUSA N/A
- GOVX N/A
- Revenue Growth
- HUSA N/A
- GOVX N/A
- 52 Week Low
- HUSA $0.96
- GOVX $1.09
- 52 Week High
- HUSA $2.57
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- HUSA 58.17
- GOVX 57.72
- Support Level
- HUSA $1.34
- GOVX $1.75
- Resistance Level
- HUSA $1.42
- GOVX $3.88
- Average True Range (ATR)
- HUSA 0.10
- GOVX 0.30
- MACD
- HUSA 0.00
- GOVX 0.15
- Stochastic Oscillator
- HUSA 63.89
- GOVX 44.60
About HUSA Houston American Energy Corporation
Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.